Health Insurers' Universal Uncertainty

Recs

6

Panic 2008... Profit 2009!

Fool -- Now's the time to invest! David and Tom Gardner's new book reveals their strategy for million dollar wealth.

One thing is universal about the stock market: In bull and bear markets, from mining to health care to retail, investors hate uncertainty. That which is known -- even bad news -- they can handle. But if investors don't know what's going to happen, the worst-case scenario usually gets priced in substantially.

Such is the case for health insurers. Usually, an election brings certainty and closure, but for health insurers, Barack Obama's plan to ensure that all Americans have health insurance breeds more questions than answers. That fogginess has been holding down the prices of the insurers shares.

Company

(Decrease) in share price since the election

UnitedHealth Group (NYSE: UNH)

(11.7%)

Humana (NYSE: HUM)

(15.8%)

Coventry Health Care (NYSE: CVH)

(19.9%)

Aetna (NYSE: AET)

(19.1%)

Cigna (NYSE: CI)

(39.8%)

WellPoint (NYSE: WLP)

(14.6%)

Source: Capital IQ, a division of Standard and Poor's.

Health care for all
The uncertainty stems from the fact that it isn't just Obama's unilateral decision about the best way to get all American's covered; 535 legislators also get to have their say, which leads to a wide variance in what the final product could look at. That could also be why Obama asked Tom Daschle to be Secretary of Health and Human Services -- he has a lot of experience dealing with legislators, since he was the Democratic leader in the Senate for 10 years.

One extreme possibility would be a government-run nationalized health care plan like the systems in Europe. That seems unlikely, but it would pretty much end the role of private health insurers as we know it.

It seems most likely that the insurance companies will end up in a partnership with the government. There's certainly precedence for public-private system, with Medicare Advantage and the Federal Employees Health Benefits Plan. The system is likely to come with lower margins for the private insurers, but hopefully the health insurers would be able to make that up with larger volumes, if everyone is covered.

The biggest problem with a low-margin system is that when the companies guess wrong by underestimating the cost of health care, the losses will be magnified. That was especially true of Humana's Medicare drug program, which hurt the company substantially earlier this year when the company overestimated its members' use of high-cost drugs.

The lower margins -- and depressed stock prices -- could spur some consolidation in the industry. That wouldn't be such a bad thing for investors, since fixed costs eat into shareholders' profits.

The added benefit of a majority of people being insured is that it could lower the costs of insuring members in the companies' commercial programs. People who always have insurance tend to be cheaper to insure, since they're less likely to let medical problems fester by waiting to get insurance before they seek help.

Economy First
Between AIG (NYSE: AIG), the car companies, the banks, and you and I, it seems that fixing health care will take a back seat for the new administration -- at least for a while.

Fortunately, stimulating the economy will benefit insurers, since they make money by investing the premiums they collect before paying for services. A stronger economy with a higher employment rate will also result in more people being insured, leading to higher revenue -- at least under the current system.

Unfortunately, delay will only compound the uncertainty, which is likely to depress stock prices until something is resolved, or the idea fades into oblivion, as it did when Hillary Clinton pushed the idea during her tenure as First Lady.

For everyone's sake, hopefully Obama and Daschle get something done sooner rather than later.

"The most exciting development in my lifetime!" 15 years ago, Motley Fool founder David Gardner uncovered a secret that changed how he'd invest forever. It can make you money in up, down, and rollercoaster markets. To learn more, enter your email address now.

WellPoint and UnitedHealth are Motley Fool Inside Value selections. UnitedHealth and Coventry Health are Motley Fool Stock Advisor recommendations. The Fool owns shares of UnitedHealth. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 785447, ~/articles/articlehandler.aspx, 1/7/2009 11:22:39 PM

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Jan 7 at 4:08 PM

Market Summary

DJIA 8,769.70 -245.40 -2.72%
S&P 500 906.65 -28.05 -3.00%
NASD 1,599.06 -53.32 -3.23%
Sponsored by:

Related Tickers

Aetna, Inc.

CAPS Rating 3/5 Stars

$29.18

-1.18 (-3.89%)

Outperform527

Underperform37

Rate This Stock